MaxCyte (MXCT) Competitors $2.65 +0.05 (+1.92%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$2.66 +0.00 (+0.19%) As of 04/15/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MXCT vs. TASK, SEZL, OLO, PRSU, PSFE, FVRR, RDWR, CTOS, IIIV, and TRMRShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include TaskUs (TASK), Sezzle (SEZL), OLO (OLO), Pursuit Attractions & Hospitality (PRSU), Paysafe (PSFE), Fiverr International (FVRR), Radware (RDWR), Custom Truck One Source (CTOS), i3 Verticals (IIIV), and Tremor International (TRMR). These companies are all part of the "business services" industry. MaxCyte vs. TaskUs Sezzle OLO Pursuit Attractions & Hospitality Paysafe Fiverr International Radware Custom Truck One Source i3 Verticals Tremor International TaskUs (NASDAQ:TASK) and MaxCyte (NASDAQ:MXCT) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and community ranking. Do insiders & institutionals believe in TASK or MXCT? 44.6% of TaskUs shares are held by institutional investors. Comparatively, 68.8% of MaxCyte shares are held by institutional investors. 29.3% of TaskUs shares are held by insiders. Comparatively, 3.0% of MaxCyte shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is TASK or MXCT more profitable? TaskUs has a net margin of 5.58% compared to MaxCyte's net margin of -78.36%. TaskUs' return on equity of 17.73% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets TaskUs5.58% 17.73% 9.17% MaxCyte -78.36%-16.00%-13.93% Which has stronger earnings & valuation, TASK or MXCT? TaskUs has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than TaskUs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTaskUs$994.99M1.18$45.69M$0.5125.51MaxCyte$38.63M7.29-$37.92M-$0.39-6.79 Does the MarketBeat Community prefer TASK or MXCT? TaskUs received 27 more outperform votes than MaxCyte when rated by MarketBeat users. However, 80.00% of users gave MaxCyte an outperform vote while only 41.05% of users gave TaskUs an outperform vote. CompanyUnderperformOutperformTaskUsOutperform Votes3941.05% Underperform Votes5658.95% MaxCyteOutperform Votes1280.00% Underperform Votes320.00% Do analysts prefer TASK or MXCT? TaskUs presently has a consensus target price of $17.86, indicating a potential upside of 37.26%. MaxCyte has a consensus target price of $8.67, indicating a potential upside of 227.04%. Given MaxCyte's stronger consensus rating and higher probable upside, analysts plainly believe MaxCyte is more favorable than TaskUs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TaskUs 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43MaxCyte 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, TASK or MXCT? TaskUs has a beta of 2.17, suggesting that its share price is 117% more volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Does the media favor TASK or MXCT? In the previous week, TaskUs had 1 more articles in the media than MaxCyte. MarketBeat recorded 7 mentions for TaskUs and 6 mentions for MaxCyte. TaskUs' average media sentiment score of 1.12 beat MaxCyte's score of 0.73 indicating that TaskUs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TaskUs 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MaxCyte 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTaskUs beats MaxCyte on 13 of the 18 factors compared between the two stocks. Remove Ads Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$281.73M$3.11B$5.33B$7.57BDividend YieldN/A2.61%5.11%4.32%P/E Ratio-7.7982.7521.7317.81Price / Sales7.29120.94379.2094.61Price / CashN/A34.5738.1534.64Price / Book1.192.326.464.00Net Income-$37.92M$118.81M$3.20B$247.23M7 Day Performance4.74%-1.88%2.85%1.45%1 Month Performance-19.45%-17.37%-8.55%-6.24%1 Year Performance-33.58%-12.32%10.46%0.60% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyte2.3006 of 5 stars$2.65+1.9%$8.67+227.0%-31.7%$281.73M$38.63M-7.7980News CoverageGap DownHigh Trading VolumeTASKTaskUs3.0394 of 5 stars$11.57-10.4%$17.86+54.3%+20.0%$1.04B$994.99M19.6149,500Short Interest ↓Positive NewsHigh Trading VolumeSEZLSezzle3.6663 of 5 stars$30.56+6.5%$61.42+101.0%+290.7%$1.03B$271.13M3.25540Short Interest ↑News CoverageOLOOLO3.1521 of 5 stars$5.90+0.8%$8.67+47.0%+25.5%$978.66M$284.94M-58.94710Short Interest ↑News CoveragePositive NewsHigh Trading VolumePRSUPursuit Attractions & Hospitality1.6529 of 5 stars$30.73-0.8%$50.00+62.7%N/A$865.05M$366.49M61.464,035Gap DownPSFEPaysafe1.9225 of 5 stars$13.84-2.3%$17.88+29.2%+1.1%$840.79M$1.70B-36.413,500Positive NewsHigh Trading VolumeFVRRFiverr International2.7927 of 5 stars$23.45+5.6%$34.22+45.9%+26.0%$840.61M$391.48M49.90790RDWRRadware3.2392 of 5 stars$19.81+0.3%$27.00+36.3%+28.3%$831.92M$274.88M141.511,140Short Interest ↑Positive NewsCTOSCustom Truck One Source2.3408 of 5 stars$3.63+3.0%$5.88+62.1%-38.0%$817.99M$1.80B-22.661,800News CoverageGap DownIIIVi3 Verticals3.977 of 5 stars$23.25-2.1%$29.86+28.4%+9.2%$768.97M$236.56M5.181,640News CoveragePositive NewsHigh Trading VolumeTRMRTremor InternationalN/AN/AN/AN/A$726.18M$343.77M-71.43167 Remove Ads Related Companies and Tools Related Companies TaskUs Alternatives Sezzle Alternatives OLO Alternatives Pursuit Attractions & Hospitality Alternatives Paysafe Alternatives Fiverr International Alternatives Radware Alternatives Custom Truck One Source Alternatives i3 Verticals Alternatives Tremor International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MXCT) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.